drugset / Trial / NCT00633204
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
Phase 2
Unknown
150 enrolled
Iwate Medical University
Human Genome Center, Institute of Medical Science, University of Tokyo · collab
NaSingle-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the clinical efficacy for the prevention of the recurrence for bladder cancer after TUR-Bt
Timeline
- Start
- 2008-02
- Primary completion
- 2011-11
- Completion
- 2011-11
Publications
- Results Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y. Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. Cancer Res. 2007 Apr 1;67(7):3276-85. doi: 10.1158/0008-5472.CAN-06-3748.
- Results Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene. 2007 Sep 27;26(44):6448-55. doi: 10.1038/sj.onc.1210466. Epub 2007 Apr 23.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEPDC1-9-294 | Unknown | — | Subcutaneous |
| Subject | MPHOSPH1-9-278 | Unknown | — | Subcutaneous |